Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
29,400,279
-
Shares change
-
+5,001,879
-
Total reported value, excl. options
-
$1,142,135,791
-
Value change
-
+$191,634,667
-
Put/Call ratio
-
331%
-
Number of buys
-
82
-
Number of sells
-
26
-
Price
-
$38.85
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q1 2019
As of 31 Mar 2019 Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) had 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,400,279 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, Redmile Group, LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, BB BIOTECH AG, BOXER CAPITAL, LLC, Partner Fund Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, and Point72 Asset Management, L.P..
This table shows 109 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.